Chaudhari Kapil S, Akamanchi Krishnacharya G
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga (E), Mumbai, India, 400019.
ACS Biomater Sci Eng. 2018 Dec 10;4(12):4008-4020. doi: 10.1021/acsbiomaterials.8b00953. Epub 2018 Nov 14.
The objective of the present study was to synthesize, evaluate, and explore the potential of a new class of bicephalous heterolipids (BHLs) as chemical permeation enhancers (CPEs) with emphasis on investigation of the influence of variable chain lengths of BHLs with the G-PETIM (poly(propyl ether imine)) dendron as a headgroup on skin permeation efficiency using diclofenac sodium (DS) as a model drug. These BHLs were synthesized, and chemical structures were confirmed by FT-IR, H NMR, C NMR, and ESI-MS. All BHLs were assessed for cytotoxicity and skin irritation studies that revealed their dermal safety. All respective DS gels with loaded BHLs were evaluated for skin permeation at varied concentrations, where gels with 1% concentration showed a significant increase in steady state flux (ER) as compared to the control gel and oleic acid loaded gel. The mechanism of enhanced skin permeation using BHL-loaded DS gels was examined using transepithelial electrical resistance (TEER), attenuated total reflection infrared (ATIR), and histomorphology, which showed significant reduction in the barrier integrity, alterations in the stratum corneum (SC), and compromising of the SC. These observations were concurrent with skin permeation results indicating that BHL enhancers could have wide scope as semisynthetic CPEs for transdermal drug delivery.
本研究的目的是合成、评估并探索一类新型双头杂脂质(BHLs)作为化学渗透促进剂(CPEs)的潜力,重点是研究以G-PETIM(聚(丙醚亚胺))树枝状分子作为头基的BHLs可变链长对皮肤渗透效率的影响,使用双氯芬酸钠(DS)作为模型药物。合成了这些BHLs,并通过傅里叶变换红外光谱(FT-IR)、氢核磁共振(H NMR)、碳核磁共振(C NMR)和电喷雾电离质谱(ESI-MS)确认了其化学结构。对所有BHLs进行了细胞毒性和皮肤刺激性研究,结果表明它们具有皮肤安全性。对所有负载BHLs的相应DS凝胶在不同浓度下进行了皮肤渗透评估,其中1%浓度的凝胶与对照凝胶和负载油酸的凝胶相比,稳态通量(ER)显著增加。使用跨上皮电阻(TEER)、衰减全反射红外光谱(ATIR)和组织形态学研究了使用负载BHL的DS凝胶增强皮肤渗透的机制,结果显示屏障完整性显著降低、角质层(SC)发生改变以及SC受损。这些观察结果与皮肤渗透结果一致,表明BHL增强剂作为半合成CPEs用于透皮给药可能具有广泛的应用前景。